Trial Details

TERMINATED
Basic Information
Clinical ID c1537
Identifier NCT03209232
Trial Title Infliximab Accelerated Induction in Moderate to Severe Pediatric UC
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Infliximab
Participant Information
Sponsor Schneider Children's Medical Center, Israel
City Petaẖ Tiqwa
Country/Region Israel
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2018-04-16
Primary Completion Date 2021-09-01
Completion Date 2021-09-01